[57] observed that MRPL9 promoted cell proliferation, migration, and invasion of lung cancer cells by regulating c-MYC and its overexpression was associated with a poor prognosis in lung cancer patients, indicating that MRPL9 may be a potential therapeutic target for lung cancer. This evidence concerns the gene MRPL9 and lung carcinoma.